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ABSTRACTS
Rubus coreanus Miquel (RCM), one a type of edible red raspberry, grows wild in Korea and China and its unripe fruit has been
used as a folk medicine for the treatment of impotence and as a diuretic agent. The goal of this study was to investigate the effects
of RCM on the proliferation and differentiation of mouse osteoblast-like MC3T3-E1 cells. In this study, RCM extract (1-10 μg/mL)
enhanced the viability of osteoblast cell. RCM extract also increased alkaline phosphatase (ALP) activity and osteocalcin secretion
of MC3T3-E1 cells (significant at 1-10 μg/mL). Especially, at a concentration of 10 μg/mL ALP activity was increased by approximately 4.3 times in comparison with the control. Alizarin red staining and osteocalcin secretion assay showed that RCM extract
stimulates differentiation of osteoblast cells by inducing the activation of mineralization. Moreover, reverse transcriptase polymerase
chain reaction and western blotting assay indicated that RCM extract induced the differentiation at mRNA and protein level. These
results suggest that RCM extract enhanced the osteoblast function by increasing the proliferation and differentiation of osteoblast like
MC3T3-E1 cells.
Key words: Rubus coreanus Miquel, osteoblast, bone formation, proliferation, alkaline phosphatase, mineralization

INTRODUCTIONS
Bone is mineralized connective tissue in vertebrates
that supports body weight, enables locomotion of the
organism, protects internal organs from external force,
and maintains mineral homeostasis. Bone homeostasis is
ensured by the balance between bone formation and bone
resorption, which depend on osteoblasts and osteoclasts,
respectively. Thus, control of the recruitment, proliferation and differentiation of these cells is essential for the
maintenance of bone mass. Disturbances in any of these
processes result in systemic or local bone diseases such
as osteoporosis, osteomalasia and periodontal diseases,
and impair the healing of fractures (1-3). Osteoporosis,
which is associated with estrogen deficiency after menopause, is the most common cause of age-related bone
loss in women(4). Estrogen replacement therapy, which
is recommended only for women who are at high risk of
osteoporosis and without any contraindication, appears
to be the most effective method for reducing the rate of
postmenopausal bone loss, although some side-effects
* Author for correspondence. Tel: +82-53-580-5538;
Fax: +82-53-580-5538; E-mail: inseon@kmu.ac.kr

may occur (5). Attempts have been made to use a combination of anti-resorptive agents, such as estrogen, and
bone formation-stimulating agents, such as a growth
hormone, in the treatment of osteoporosis (6). However,
the potential bone-forming agents currently available
either may have serious side-effects, or may not improve
bone quality to reduce the susceptibility to fracture.
Thus, the discovery of a natural dietary substance that
minimizes bone loss in postmenopausal women would be
of great interest.
Plants that are used in folk medicine have been
recognized as one of the main sources in drug discovery and development. Because natural products of plant
origin are still a major part of traditional medicinal
systems, a resurgence of interest in herbal medicines has
occurred in western countries as an alternative source
of drugs often for intractable diseases such as rheumatoid arthritis (7). From ancient times in China, Japan and
Korea, women who have had lower back pain in climacteric and senescent periods have been treated with traditional medicines (8).
One of the traditional medicines, Rubus coreanus Miquel (RCM), a type of red raspberry, grows wild
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in Korea and China and its unripe fruit is used as a folk
medicine for the treatment of impotence and as a diuretic.
The botanical origin of the Rubi Fructus in the Korean
crude drug market is mostly derived from fruits of R.
crataegifolius and is sometimes mixed with the fruit of
R. parvifolius which is closely related to R. phoenicolasius(9). The fruits are rich in sugars, organic acids and
several vitamins, as well as triterpenoids (10,11), and also
include various anti-oxidants, tannins (12) and phenolic
acids (13). Extract of the fruit have been found to show
considerable antioxidant activity in various test systems
regardless of the degree of ripeness (14).
Unripe fruits of RCM are used, not only as food, but
also to remit diabetes mellitus and sexual disinclination as
a drug component in herbal medicine(15,16), therefore, it is
thought to contain diverse functional substances. In studies on RCM, flavonoids complexes have been isolated from
its leaves and stems(17), and it has been reported to contain
antioxidants such as quercetin, gallic acid, 2,3-(S)-HHDPD-glycopyranose, sanguine, etc.(18,19). Therefore, based
on analyses of its components and biological activities,
we examined the relationship between bone cells and the
RCM extract, which may contribute to the justification for
the clinical application in the treatment of metabolic bone
disease. It is shown that an acceleration effect is exerted
by extract of RCM on the proliferation and differentiation
of murine osteoblast like MC3T3-E1 cells.

MATERIALS AND METHODS
I. Cell Culture
MC3T3-E1 cells derived form newborn mouse calvaria and purchased from ATCC (CRL-2593, USA), were
grown in α-MEM (Gibco BRL, NY, USA) supplemented
with 10% fetal calf serum (Gibco) at 37°C in a humidified
atmosphere of 5% CO2, and the medium was changed at
3-day intervals. After the cells reached confluence, they
were switched to the differentiation medium (α-MEM
containing 50 μg/mL of the phosphate ester of ascorbic
acid (Sigma, MO, USA) and 10 mM β-glycerophosphate
(Sigma) in the absence or presence of various doses of
RCM, which was dissolved in distilled water.
II. Preparation of Rubus coreanus Miquel Extract
Unripe fruits of R. coreanus Miquel were purchased
from Yakryeong (Drug) Market (Dae-gu, Korea). The
dried plant material (4.0 kg) was extracted three times
with 80% methanol under reflux for 5 hr and the supernatant was filtered with a 10-μm paper cartridge. The
filtered extract was concentrated on a rotary evaporator
(Eyela, Tokyo, Japan) under reduced pressure to give a
viscous methanol extract (450 g). The concentrated
extract was freeze-dried. Brown powder (230 g) was
generally produced in this process. A voucher specimen

has been deposited at the Department of Food Science
and Technology, Keimyung University, Daegu, Korea.
III. Cell Viability Assay
Effect of RCM extract on the proliferation of osteoblasts was investigated by MTT assay, as described by
Green et al.(20) where the reduction of (3-(3,4-dimethylthiazolyl-2)- 2,5-diphenyltetrazolium bromide reagent
(MTT) was measured. Cultured cells were counted using
0.4% trypan blue and adjusted to 1×10 4 cells/well. RCM
extract was added in at final concentrations of 1, 5, 10,
and 100 μg/mL, and the incubation lasted for 48 hr. Vehicle of 20 μL of α-MEM media with no supplement was
added to the culture medium as a control. After the incubation, 10 μL of MTT reagent of 5 mg/mL was added, to
each well, followed by 4-hr incubation. The medium was
then removed and the wells were washed twice with PBS.
One hundred microliter of DMSO was then added in to
solubilize the generated insoluble formazan crystals and
the optical density (OD) was measured at 550 nm in an
ELISA reader (Spectra MAX 340 pc, Molecular Device,
USA). Cell proliferation is indicated as the percentage of
the OD of samples to that of the control group.
IV. Determination of Alkaline Phosphatase Activity and
Staining
MC3T3-E1 cells were grown in 96-well plates and
treated with RCM extract for 12 days. After incubation,
the cells were rinsed twice with ice cold phosphate buffered saline (PBS, pH 7.4) and resuspended in Tris / glycine
/ triton buffer (50 mM Tris, 100 mM glycine, 0.1% triton
X-100, pH 10.5). The supernatant was collected by centrifugation at 5,000 ×g for 15 min at 4°C. Ten microliter of pnitrophenyl-phosphate (p-NPP) substrate (100 mM) mixed
with 20 μL of 0.1N glycine NaOH (pH 10.4) was added to
20 μL of the supernatant and incubated at 37°C for 30 min.
The enzymatic reaction catalyzed by alkaline phosphates
(ALP) was stopped by adding 200 μL of 0.1 N NaOH. The
OD of p-nitrophenol (p-NP) product was measured at 405
nm within 1 hr. ALP activity was standardized as the relative control %. MC3T3-E1 cells grown in 24-well plates
were treated with RCM extract for 12 days, and ALP was
stained using an alkaline phosphatase kit (Sigma). Briefly,
after the culture medium was removed, fixative (citrateacetone-formaldehyde) was added and kept for 30 sec at
room temperature, and the cells were rinsed with distilled
water for 45 sec. A diazonium solution (sodium nitrite:
FRV-alakline : naphthol AS-BI alkaline solution = 1:1:1)
was added, followed by incubation for 15 min at room
temperature, and the cells were washed with distilled
water for 2 min. The cell cultures were stained again
with a hematoxylin solution for 2 min, and then washed
with running water and examined under a microscope(21).
To determine the protein expression of ALP in osteoblast cells, the western blot analysis was performed. The
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V. Determination of the Level of Calcification by AlizarinRed Staining
After 12 days of incubation with RCM extract in
96-well plate, the calcium deposition of MC3T3-E1
cell cultures were revealed by staining with alizarinred (AR) solution. The cells were rinsed with PBS, and
fixed with 70% EtOH at 4°C for 1 hr. AR solution was
freshly prepared as follows: 40 mM of alizarin red was
dissolved in 10 mL distilled water, and the pH adjusted to
4.2. After fixing, the cells were stained with the AR solution for 10 min, washed twice with distilled water. The
unstained area was washed with PBS and soaked with
PBS to prevent drying. The level of the nodule formation was examined under a microscope. AR staining was
released from the cell matrix by incubation in 10% cetylpyridinium chloride in 10 mM sodium phosphate (pH
7.0) for 15 min. The AR concentration was determined
by measuring the absorbance at 562 nm(22).
VI. Measurement of Osteocalcin
After the cells were cultured to 1 × 104 cells/well in a
culture dish for 12 days, the culture medium was replaced
with α-MEM containing 5% CD-FBS. The cells were then
cultured with RCM extracts in the presence of β-GP (10
mM) and vitamin C (50 ng/mL) and the osteocalcin content
in the culture medium was measured using a sandwich
ELISA assay kit (Biomedical Technologies Inc., USA). Two
mouse osteocalcin antibodies were employed, each directed
toward one end (C- or N-terminal) of the osteocalcin molecule. The N-terminal antibody is attached bound to the
well, which in turns binds the mouse osteocalcin in standard
or sample. The biotin-labeled C-terminal mouse osteocalcin
antibody completes the sandwich. This sandwich ELISA kit
was specific for intact mouse osteocalcin only. Both carboxylated and decarboxylated mouse osteocalcin were recog-

nized. The osteocalcin secretion was normalized by total
protein content. The total protein was determined using of
BCA protein assay kit (Bio-Rad, CA, USA).
VII. Reverse Transcription-polymerase Chain Reaction
(RT-PCR)
Total RNA was extracted from osteoblast-like
cells grown in 100 mm tissue culture dishes of modified
surfaces using Trizol reagent (GibcoBRL, Grand Island,
NY). RT-PCR was performed using the TAKARA RTPCR kit (Takara). The PCR products were analyzed
by electrophoresis using a 2% agarose gel. Primer pairs
for ALP (F:5’-CCA AGACGTACAACACCAACGC-3’,
R: 5’-AAATGCTGATGAGGTCCAGG-3’), OCN(F: 5’AAATGCTGATGAGGTCCAGGC-3’, R: 5’-ACCGTAGATGCGTTTGTAGGC-3’), Collagen type I (F: 5’-CTCCGGCTCCTGCTCCTCTTA-3’,R:5’-GCACAGCACTCGCCCTCCC-3’),
OPN (F: 5’-GATGAATCTGACGAATCTAC-3’, R: 5’CTGCTTAATCCTCACTAACAC-3’), GAPDH (F: 5’
– TGAGAACGGGAAGCTTGTCA-3’, R: 5’-GGAAGGCCATGCCAGTGA-3’) were used.
VIII. Statistical Analysis
The data were expressed as mean ± S.D. Statistical
analysis was performed by one-way ANOVA (p < 0.05)
using SAS statistical software.

RESULTS
I. Effect of RCM on the Proliferation of MC3T3-E1 Cells
The effect of RCM at concentrations of 1, 5, 10, 100
μg/mL on the growth of mouse osteoblast-like MC3T3-E1
cells was investigated by an MTT assay(23). The proliferation of MC3T3-E1 cells cultured with 5 μg/mL RCM
extract was boosted by up to 152% in comparison with the
control. The following values were found for other concen-

200

Cell viability (%)

cultured cells were treated with RCM for 12 days. The
cells were washed twice with PBS and then lysed, homogenized and sonicated in a RIPA lysis buffer containing 0.5
M Tris-HCl (pH 7.4), 1.5 M NaCl, 2.5% deoxycholic acid,
10% NP-40 and 10 mM EDTA. The cytosolic fraction was
collected as a supernatant after centrifugation at 125,000
×g for 10 min at 4°C. Twenty microgram protein was denatured in SDS sample buffer and resolved on the 10% SDSpolyacrylamide gel. Proteins were transferred in 25 mM
Tris, 192 mM glycine, and 20% methanol to polyvinylidene difluoride (PVDF) membrane. Blots were blocked
with Tris-buffered saline [20 mM Tris-HCl (pH 7.5) and
137 mM NaCl] plus 0.1% Tween 20 containing 3% dried
milk powder. After blocking, the membrane was probed
with anti-alkaline phosphatase (Abcam Ltd, Cambridge,
UK), and then with peroxidase-labeled antibodies raised
against rabbit IgG being used as second antibodies. Peroxidase activity on the PVDF sheet was visualized on X-ray
film using an ECL western blotting detection system.
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Figure 1. Effect of RCM on the proliferation on MC3T3-E1 cells.
Viable cells, as determined by MTT assay. MC3T3-E1 cells (1×
10 4 cell/well) were plated and cultured 48 hr in the absence (V) or
presence of different concentrations of RCM (1-100 μg/mL). Each bar
represents means ± SD. *p < 0.05 vs. control. V, vehicle control.
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trations: 1 μg/mL, over 131%; 10 μg/mL, 142%; and 100
μg/mL, lower than 90% (Figure 1). Therefore, the optimal
concentration of RCM extract without any inhibitory effect
was determined to be in the range of 1-10 μg/mL.
II. Effect of RCM on the Alkaline Phosphatase Activity of
MC3T3-E1 Cells
Osteoblast cells were adjusted to 1 × 10 4 cells/well
in the differentiation medium, which was treated with
the RCM extract at concentrations of 1-100 μg/mL, and
incubated for 12 days, and the ALP enzyme activity was
then determined. As shown in Figure 2A, ALP activity of MC3T3-E1 cells cultured with RCM at 10 μg/mL
increased by 4.3 folds at 12 days ( p < 0.05). Total protein
extracts were also examined for ALP protein expression
by Western blotting (Figure 2B).
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To confirm the induction of the ALP enzyme in osteoblasts, the AZO staining method was employed. Naphthol AS-BI phosphate is hydrolyzed into orthophosphate
and naphthol by ALP present in tissues and the released
naphthol binds to the diazonium compound present in the
reaction mixture, forming an AZO dye, which thus stains
the active site of the enzyme red. The RCM extract was
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III. Effect of RCM by the Staining
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added at a concentration of 10 μg/mL, cells were cultured
for 12 days and the staining level of the ALP enzyme in
cells was assessed. As shown in Figure 3A, in the control
group without any RCM treatment, the red enzyme was
not formed abundantly. On the other hand, in the group
treated with the RCM extract, the red stained enzyme
was generated in large quantity, and the cells were found
changed to red overall. Therefore, it is confirmed that the
activation of ALP is induced in osteoblasts by the RCM
extract. Also, calcification formation was examined by the
Alizarin-Red staining method. Consistent with ALP activity result, increased mineralization/bone nodule formation was observed upon the treatment with RCM (Figure
3B). The Alizarin-Red concentration was determined by
measuring the absorbance at 562 nm (Figure 3C).
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Figure 2. Effect of RCM on the alkaline phosphatase activity in
MC3T3-E1 cells. (A) ALP activity was determined with extracellular
enzyme. MC3T3-E1 cells were seeded at 70~80% density in 96 well
plate and grown for 12 days in α-MEM containing 10% FBS, vitamin
C (50 ng/mL), and β-glycerophosphate (10 mM). Cells were treated
with the indicated concentrations of RCM extract. (B) Total protein
extracts were also examined for ALP protein expression by Western
blotting. MC3T3-E1 cells were seeded at 70~80% density in 6well
plate. After 24 hr incubation, the medium exchanged with α-MEM
containing 10% FBS, vitamin C (50 ng/mL), and β-glycerophosphate
(10 mM). Cells were also treated with the indicated concentrations
of RCM extract for 12 days. β-actin was used as an internal control.
Each bar represents means ± SD. *p < 0.05 vs. control.

Figure 3. Effect of RCM extract on MC3T3-E1. Cells were cultured
with α-MEM containing 10% FBS, 50 μg/mL ascorbic acid, and 10
mM β-glycerol phosphate. (A) Alkaline phosphatase of extracellular
matrix by MC3T3-E1 cells. ALP staining assay was carried out with
treatment of cells with vehicle control and 10 μg/mL RCM extract.
After 12 days, cells were fixed and stained. (B) RCM-induced bone
nodules formation in MC3T3-E1 cells. Alizarin Red staining of
mineralized nodules in MC3T3-E1 cells treated with 0, 1, 5, 10, 50
μg/mL of RCM extract. Cell treatment was similar to that of ALP
staining. (C) Calcium salt deposition was determined as peak nodule
formation ratio by absorbance spectra. AR-stained cell was dissolved
with 10% cetylpyridinium chloride in 10 mM sodium phosphate (pH
7.0) for 15 min. The AR concentration was determined by measuring
the absorbance at 562 nm. Each bar represents means ± SD. *p < 0.05
vs. control.
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IV. Effect of RCM on Osteocalcin Secretion
We further investigated whether RCM plays a role
in the secretion of osteocalcin. MC3T3-E1 cells were
treated with RCM (1-10 μg/mL) extract and the content of
osteocalcin in the medium was measured (Figure 4). The
level of osteocalcin was significantly increased at 5 and
10 μg/mL of RCM extract in MC3T3-E1 cell cultures.
These results indicated that RCM stimulates osteocalcin
synthesis in osteoblasts.
V. Expression of mRNA in Osteoblast
The expression of osteoblast differentiation genes in
various concentration of RCM was also studied. After
30 cycles of PCR, products of the expected sizes were
observed for ALP, OCN, Col-I, OPN and GAPDH (Figure
5). Also, 5 and 10 μg/mL of RCM induced the expression
of differentiation gene in osteoblast cell.

DISCUSSION
This report shows that RCM significantly induce cell
proliferation and induce osteoblastic differentiation of
MC3T3-E1 cells at concentration of 1-10 μg/mL. RCM
can promote cell growth, ALP activity, osteocalcin secretion, protein expression and gene expression in osteoblastic MC3T3-E1 cells in vitro.
The preosteoblast MC3T3-E1 cell line is an excellent cell differentiation model that simulates the events
of early osteoblastogenesis (24). Cells were stimulated by
growth and differentiation factors in the culture medium
undergo series of developmental processes that include
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Figure 4. Effect of RCM on the osteocalcin secretion of MC3T3-E1
cells. T he cells were t reated with var ious concent rations of
RCM (1-10 μg/mL). Osteocalcin secretion was determined with
conditioned medium. MC3T3-E1 cells were seeded at 70~80%
density in 96-well plate and grown for 12 days in α-MEM containing
10% FBS, vitamin C (50 ng/mL), and β-glycerophosphate (10 mM).
Cells were treated with the indicated concentrations of RCM extract.
Data shown are mean ± SD., expressed as a percentage of control. *p
< 0.05 vs. control.

proliferation of undifferentiated precursors of osteoblasts,
which subsequently differentiate into post-mitotic osteoblasts capable of expressing the osteogenic phenotype.
During the proliferative phase, these cells undergo DNA
synthesis and cell division resulting in rapid increase in
cell number until the cultures become confluent. At this
juncture, proliferation is down regulated and increased
expression of the osteogenic phenotype is observed indicating the presence of mature osteoblasts. Osteoblasts
produce alkaline phosphatase, process procollagen to
collagen, and deposit extracellular matrix proteins (e.g.
osteopotin, bone sialoprotein and osteocalcin) on the
substrate, which is subsequently mineralized (25).
Rubus coreanus Miquel, is used as a folk medicine and as a diuretic. Yet, no data are available as to
the formation of bone by this folk medicine. In several
studies in which the components of RCM were examined, it was found to contain abundant level of inorganic
phosphate, iron, calcium, organic acids, vitamin C and
flavonoids. Among the flavonoids, kampferol, quercetin, sanguiin H-5, ellagic acid and 3-O-β-D-glucuronide,
etc. have been reported (26). These flavonoids have multiple beneficial biological activities owing to their antioxidant, anti-inflammatory and estrogenic effects (27,28).
Estrogen exerts bone anabolic effects by promoting
key osteoblast functions and inhibiting osteoclastogenesis (29). Estrogen actions are predominantly mediated
by its high affinity to nuclear receptors and many of the
flavonoids are considered phytoestrogens owing to their
ability to bind and signal via estrogen receptors (30). In
the context of bone health, recent reports indicate that the
isoflavonoids genistein and daidzein significantly prevent
bone loss in ovariectomized rats (31). Similar effects were
observed with the flavonol, quercetin and kaempferol(32).
To investigate the effect of RCM on bone metabolism,
we employed cell culture system. As a results, RCM
enhanced the osteocalcin secretion and mRNA expression. The level of osteocalcin was significantly increased
at 5 or 10 μg/mL of RCM extract in MC3T3-E1 cell
cultures. Horcajada-Molteni et al.(32) reported that the
effect of quercetin on bone metabolism in ovariectomized
rats. They suggested that quercetin increased not only
the osteoblastic activity but also osteocalcin concentration in plasma. Osteocalcin is a bone-specific protein and
serves as a marker for osteoblastic acivity. It comprises
about 15% of the noncollagenous protein components
of bone (33). While the function of this protein in bone
is uncertain, its conserved nature among species and its
appearance early in the process of mineralization suggest
a fundamental role for osteocalcin in the attainment and
maintenance of the bone mineral matrix, as well as in
bone remodeling(34,35).
On the other hand, Korean medicines, which have
been developed over some 3000 year (36) s, are known to
have low toxicity over long term usage (37). RCM, one
of the traditional Korean medicines, increased the ALP
activity significantly. ALP is the most widely recognized
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Figure 5. Effect of RCM on the osteoblast differentiation gene expression. (A) The gene expression examined for ALP, OCN (Osteocalcin),
Col-I (Type I Collagen), OPN (Osteopontin), GAPDH (Glyceraldehyde-3-phosphate dehydrogenase) by RT-PCR. Cells were treated with
the indicated concentrations of RCM in α-MEM containing 10% FBS, vitamin C (50 ng/mL), and β-glycerophosphate (10 mM) for 12 days.
Expression of mRNA levels was detected by PCR amplification of cDNA fragment from reverse-transcribed total RNA prepared from mouse
osteoblastic MC3T3-E1 cells. GAPDH was used as an internal control. (B) The values were normalized to GAPDH mRNA level of each
sample. Each bar represents means ± SD. *p < 0.05 vs. control.

biochemical marker for osteoblastic activity. Although
its precise mechanism of action is poorly understood, this
enzyme is believed to play a role in bone mineralization.
Therefore, we screened the effects of various Korean
traditional medicine extract (0-100 μg/mL) on the ALP
activity of osteoblastic MC3T3-E1 cells (data not shown).
Among them, RCM (1-10 μg/mL) is the most effective in
inducing the ALP activity.

Moreover, we have examined mineralization formation by the Alizarin-Red staining method. Bone nodule
formation is an important marker of the differentiation
of osteoblasts. Alizarin is a plant dye with a specifically
high affinity for calcium. This dye stains the mineralized matrix of cells, and mineralization is proportional to
the level of staining(38,39). Consistent with ALP activity
result, increased mineralization/bone nodule formation
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was observed upon the treatment with RCM. Thus, RCM
seems to stimulate the proliferation and differentiation
of osteoblasts. In addition, RCM (10 μg/mL) accelerated
mRNA and protein expression of ALP, osteocalcin, Type
I collagen and osteopontin.
In conclusion, these results suggested that RCM is
effective for bone formation in bone cells and could be
useful for preventing osteoporosis. Although the study
had limitations and our findings are preliminary, continued and advanced study on the alterations in gene expression of bone cells and on compounds of RCM will provide
a basis for understanding the observed bone cell responses to various pharmacological interventions.
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